Position history for BlackRock, Inc.'s holdings in RHYTHM PHARMACEUTICALS INC
BlackRock, Inc. holds 6.2M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $542.4M as of 2026-Q1. The position was decreased (-1.0% shares). RYTM represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$542.4M
Current Shares
6.2M
Total Value Change
+$153.3M
Total Shares Change
-713,564
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Decreased |
| 6.2M |
-1.0% |
| $542.4M |
| 0.0% |
| $89.56 |
0 |
| 2025-Q4 | Decreased | 6.3M | -0.1% | $674.1M | 0.0% | $106.76 | 0 |
| 2025-Q3 | Increased | 6.3M | +0.6% | $636.5M | 0.0% | $100.64 | 32 |
| 2025-Q2 | Decreased | 6.3M | -8.6% | $396M | 0.0% | $62.73 | 0 |
| 2025-Q1 | Decreased | 6.9M | -1.4% | $363.1M | 0.0% | $54.80 | 0 |
| 2024-Q4 | New | 7M | - | $389.1M | 0.0% | $56.34 | 43 |